Class information for:
Level 1: C ERBB 2//HER 2 NEU//P185

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5180 1661 40.3 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
317 3       HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA 39408
652 2             HER2//TRASTUZUMAB//HER 2 NEU 13568
5180 1                   C ERBB 2//HER 2 NEU//P185 1661

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 C ERBB 2 authKW 556654 9% 21% 143
2 HER 2 NEU authKW 232856 8% 10% 127
3 P185 authKW 205358 1% 62% 18
4 NEU authKW 198747 3% 25% 44
5 SERUM HER2 authKW 148276 1% 73% 11
6 C ERBB 2 ONCOPROTEIN authKW 119470 1% 50% 13
7 SERUM HER 2 NEU authKW 117642 0% 80% 8
8 ERBB2 authKW 116796 5% 8% 80
9 ONCOGENE SCI address 100077 0% 78% 7
10 CODON 655 authKW 91910 0% 100% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 21309 58% 0% 965
2 Cell Biology 1761 18% 0% 301
3 Pathology 1381 9% 0% 145
4 Medical Laboratory Technology 871 4% 0% 67
5 Biochemistry & Molecular Biology 758 21% 0% 355
6 Genetics & Heredity 536 9% 0% 146
7 Obstetrics & Gynecology 162 4% 0% 63
8 Medicine, Research & Experimental 126 4% 0% 74
9 Biotechnology & Applied Microbiology 51 4% 0% 65
10 Biochemical Research Methods 14 2% 0% 33

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOGENE SCI 100077 0% 78% 7
2 CANC WIA 36764 0% 100% 2
3 PATHOL SURG PATHOL SECT 36764 0% 100% 2
4 BREAST CANC BASIC PROGRAM 32819 0% 36% 5
5 WERPUNKT ONKOL HAMATOL 25523 0% 28% 5
6 CARDIOL THORAC VASC SURG 24508 0% 67% 2
7 RECEPTOR BIOL CELL GROWTH 24508 0% 67% 2
8 ABEITSGRP ZYTOGENET 18382 0% 100% 1
9 ANAM HOSP ONCOL HEMATOL 18382 0% 100% 1
10 ASSOCIATED REG UNIV ASSOCIATES 18382 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOGENE 8708 6% 1% 93
2 BREAST CANCER RESEARCH AND TREATMENT 7064 3% 1% 53
3 ANTICANCER RESEARCH 5322 5% 0% 75
4 BRITISH JOURNAL OF CANCER 3257 3% 0% 57
5 DIAGNOSTIC ONCOLOGY 3088 0% 4% 4
6 INTERNATIONAL JOURNAL OF CANCER 2680 3% 0% 55
7 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 2455 1% 1% 11
8 CANCER RESEARCH 2082 4% 0% 68
9 JAPANESE JOURNAL OF CANCER RESEARCH 1470 1% 0% 17
10 INTERNATIONAL JOURNAL OF ONCOLOGY 1467 2% 0% 28

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 C ERBB 2 556654 9% 21% 143 Search C+ERBB+2 Search C+ERBB+2
2 HER 2 NEU 232856 8% 10% 127 Search HER+2+NEU Search HER+2+NEU
3 P185 205358 1% 62% 18 Search P185 Search P185
4 NEU 198747 3% 25% 44 Search NEU Search NEU
5 SERUM HER2 148276 1% 73% 11 Search SERUM+HER2 Search SERUM+HER2
6 C ERBB 2 ONCOPROTEIN 119470 1% 50% 13 Search C+ERBB+2+ONCOPROTEIN Search C+ERBB+2+ONCOPROTEIN
7 SERUM HER 2 NEU 117642 0% 80% 8 Search SERUM+HER+2+NEU Search SERUM+HER+2+NEU
8 ERBB2 116796 5% 8% 80 Search ERBB2 Search ERBB2
9 CODON 655 91910 0% 100% 5 Search CODON+655 Search CODON+655
10 C ERBB 2 PROTEIN 75613 1% 34% 12 Search C+ERBB+2+PROTEIN Search C+ERBB+2+PROTEIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 HYNES, NE , STERN, DF , (1994) THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1198. ISSUE 2-3. P. 165-184 147 61% 774
2 REVILLION, F , BONNETERRE, J , PEYRAT, JP , (1998) ERBB2 ONCOGENE IN HUMAN BREAST CANCER AND ITS CLINICAL SIGNIFICANCE.EUROPEAN JOURNAL OF CANCER. VOL. 34. ISSUE 6. P. 791 -808 111 63% 330
3 DAWKINS, HJS , ROBBINS, PD , SMITH, KL , SAMA, M , HARVEY, JM , STERRETT, GF , PAPADIMITRIOU, JM , (1993) WHATS NEW IN BREAST-CANCER - MOLECULAR PERSPECTIVES OF CANCER DEVELOPMENT AND THE ROLE OF THE ONCOGENE C-ERBB-2 IN PROGNOSIS AND DISEASE.PATHOLOGY RESEARCH AND PRACTICE. VOL. 189. ISSUE 10. P. 1233 -1252 132 75% 26
4 DOUGALL, WC , QIAN, XL , PETERSON, NC , MILLER, MJ , SAMANTA, A , GREENE, MI , (1994) THE NEU-ONCOGENE - SIGNAL-TRANSDUCTION PATHWAYS, TRANSFORMATION MECHANISMS AND EVOLVING THERAPIES.ONCOGENE. VOL. 9. ISSUE 8. P. 2109-2123 96 63% 209
5 MATHELIN, C , CROCE, S , RAULT, S , GHARBI, M , EICHLER, F , GAIRARD, B , COUMAROS, G , KOEHL, C , (2011) CLINICAL USEFULNESS OF CIRCULATING ECD/HER-2 MEASUREMENT FOR BREAST CANCER PATIENTS ' MANAGEMENT.PRESSE MEDICALE. VOL. 40. ISSUE 2. P. 126 -137 61 70% 3
6 MOLINA, R , ESCUDERO, JM , FILELLA, X , AUGE, JM , MUNOZ, M , (2012) CIRCULATING LEVELS OF HER-2/NEU ONCOPROTEIN IN BREAST CANCER.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 50. ISSUE 1. P. 5 -21 76 50% 9
7 CARNEY, WP , NEUMANN, R , LIPTON, A , LEITZEL, K , ALI, S , PRICE, CP , (2003) POTENTIAL CLINICAL UTILITY OF SERUM HER-2/NEU ONCOPROTEIN CONCENTRATIONS IN PATIENTS WITH BREAST CANCER.CLINICAL CHEMISTRY. VOL. 49. ISSUE 10. P. 1579-1598 62 69% 101
8 SINGLETON, TP , STRICKLER, JG , (1992) CLINICAL AND PATHOLOGICAL SIGNIFICANCE OF THE C-ERBB-2 (HER-2/NEU) ONCOGENE.PATHOLOGY ANNUAL. VOL. 27. ISSUE . P. 165 -190 82 84% 5
9 LEARY, AF , HANNA, WM , VAN DE VIJVER, MJ , PENAULT-LLORCA, F , RUSCHOFF, J , OSAMURA, RY , BILOUS, M , DOWSETT, M , (2009) VALUE AND LIMITATIONS OF MEASURING HER-2 EXTRACELLULAR DOMAIN IN THE SERUM OF BREAST CANCER PATIENTS.JOURNAL OF CLINICAL ONCOLOGY. VOL. 27. ISSUE 10. P. 1694-1705 60 57% 43
10 KLAPPER, LN , KIRSCHBAUM, MH , SELA, M , YARDEN, Y , (2000) BIOCHEMICAL AND CLINICAL IMPLICATIONS OF THE ERBB/HER SIGNALING NETWORK OF GROWTH FACTOR RECEPTORS.ADVANCES IN CANCER RESEARCH, VOL 77. VOL. 77. ISSUE . P. 25 -79 118 27% 399

Classes with closest relation at Level 1


Rank Class id link
1 6321 HER2//HER 2 NEU//TOP2A
2 35026 M1B PROSTATE CANCER//BIOMARKER EPIDERMAL GROWTH FACTOR RECEPTOR EGFR//C ERB B 2 NEU GENE
3 2563 TRASTUZUMAB//LAPATINIB//PERTUZUMAB
4 13462 HER2//GASTRIC CANCER//HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
5 4433 NEUREGULIN//NEUREGULIN 1//ERBB4
6 16780 CANC VACCINE DEV PROGRAM//CANC IMMUNOL IMMUNOTHER Y//TUMOR VACCINE GRP
7 13947 P53//AREA BIOPATOL//BCL 2
8 12629 OVARIAN CANCER//OVARIAN CARCINOMA//CANC MONTREAL
9 5515 TRANSFORMING GROWTH FACTOR ALPHA//TGF ALPHA//TGF ALPHA ASE
10 24042 FUSED TOES HOMOLOG//PAN RAS//A RADIATION DOSE OF 27 GY

Go to start page